Brief: Concerned Shareholders Of Aurinia Pharmaceuticals Announce Their Intention To Withhold Support For CEO Peter Greenleaf At 2025 Annual Meeting
23/04/2025 21:58
April 23 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O: CONCERNED SHAREHOLDERS OF AURINIA PHARMACEUTICALS ANNOUNCE THEIR INTENTION TO WITHHOLD SUPPORT FOR CEO PETER GREENLEAF AT 2025 ANNUAL MEETING MARKET CAPITAL AND LUCIEN SELCE: BELIEVE AURINIA SHAREHOLDERS WOULD BENEFIT FROM A LEANER, MORE ACCOUNTABLE BOARD Source text: ID:nBwbr9WfNa Further company coverage: AUPH.O ((Reuters.Briefs@thomsonreuters.com))
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death